Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading MeiraGTx Holdings plc chart...

About the Company

meiragtx, a london and new york-based gene therapy company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. we are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as alzheimer’s disease (ad), parkinson’s disease (pd), and amyotrophic lateral sclerosis (als). we are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (amd). meiragtx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.

CEO

Alexandria Forbes

Exchange

NASDAQ

Website

http://meiragtx.com/

$98M

Total Revenue

347

Employees

$394M

Market Capitalization

-2.49

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $MGTX News

MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why

2mon ago, source: Hosted on MSN

MeiraGTx Holdings plc MGTX is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. The company has six gene ...

MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023

4d ago, source:

Gain on Sale of Assets: A significant gain of $54.2 million was recorded from the sale of nonfinancial assets to Janssen.

MeiraGTx Holdings plc (NASDAQ:MGTX) stock most popular amongst private equity firms who own 28%, while individual investors hold 26%

22d ago, source: Yahoo Finance

Significant control over MeiraGTx Holdings by private equity ... 19% To get a sense of who is truly in control of MeiraGTx Holdings plc (NASDAQ:MGTX), it is important to understand the ownership ...

MeiraGTx Holdings PLC MGTX

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Commit To Purchase MeiraGTx Holdings At $5, Earn 16.4% Annualized Using Options

1mon ago, source: Nasdaq

Investors considering a purchase of MeiraGTx Holdings PLC (Symbol: MGTX) shares, but cautious about paying the going market price of $6.35/share, might benefit from considering selling puts among ...

MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates

4d ago, source: Nasdaq

MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.58 per share a year ago. These ...

MeiraGTx Holdings PLC MGTX

10d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

MeiraGTx Holdings plc (NASDAQ:MGTX) stock most popular amongst private equity firms who own 28%, while individual investors hold 26%

21d ago, source: Yahoo Finance

This can be negative in some circumstances. We can see that insiders own shares in MeiraGTx Holdings plc. In their own names, insiders own US$18m worth of stock in the US$369m company. This shows at ...

MeiraGTx Holdings PLC

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

MeiraGTx Holdings plc (MGTX)

18d ago, source: Yahoo Finance

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the achievement of the first milestone under the asset purchase agreement the ...

MeiraGTx Holdings plc (MGTX)

25d ago, source: Yahoo Finance

The average of price targets set by Wall Street analysts indicates a potential upside of 217.9% in MeiraGTx Holdings PLC (MGTX). While the effectiveness of this highly sought-after metric is ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...